Keep ‘em com­ing: Lux Cap­i­tal bags $1.15B as life sci­ences funds reel in one round af­ter an­oth­er in 2023

Lux Cap­i­tal has closed its largest fund to date — at $1.15 bil­lion — in the eighth it­er­a­tion of its cap­i­tal-dol­ing prac­tice.

The New York-based in­vest­ment firm is one of at least half a dozen to dis­close new biotech funds this year, in­clud­ing Welling­ton’s $476 mil­lion this morn­ing.

In its an­nounce­ment, Lux said in­vest­ments could span the gamut of that first $100,000 check to the last $100 mil­lion be­fore an ex­it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER